ArticleTranslational cancer research2025

A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in

Ji Yeon Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.